(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 7.30%108.97M | -2.42%212.59M | -9.11%153.54M | -17.39%101.55M | -20.47%46.67M | -12.52%217.86M | -7.88%168.93M | 0.52%122.93M | 6.73%58.68M | 45.16%249.04M |
Operating income | 7.30%108.97M | -2.42%212.59M | -9.11%153.54M | -17.39%101.55M | -20.47%46.67M | -12.52%217.86M | -7.88%168.93M | 0.52%122.93M | 6.73%58.68M | 45.16%249.04M |
Cost of sales | -8.82%-82.86M | 1.37%-157.68M | 8.36%-113.87M | 15.10%-76.14M | 19.74%-34.86M | 16.17%-159.87M | 12.99%-124.26M | 6.33%-89.68M | -1.12%-43.43M | -38.99%-190.7M |
Operating expenses | -8.82%-82.86M | 1.37%-157.68M | 8.36%-113.87M | 15.10%-76.14M | 19.74%-34.86M | 16.17%-159.87M | 12.99%-124.26M | 6.33%-89.68M | -1.12%-43.43M | -38.99%-190.7M |
Gross profit | 2.73%26.11M | -5.31%54.91M | -11.18%39.68M | -23.57%25.41M | -22.54%11.81M | -0.60%57.99M | 10.12%44.67M | 25.25%33.25M | 26.71%15.25M | 69.81%58.34M |
Selling expenses | -2.28%-5.61M | 9.56%-13.03M | 17.08%-9.08M | 32.87%-5.48M | 41.25%-2.62M | -2.76%-14.41M | -14.31%-10.95M | -41.89%-8.16M | -70.85%-4.46M | -38.17%-14.02M |
Administrative expenses | 7.96%-15.58M | -11.99%-36.18M | -15.42%-26.68M | -6.45%-16.93M | 8.20%-6.85M | 2.58%-32.31M | -5.44%-23.12M | -8.12%-15.91M | -6.25%-7.47M | -1.32%-33.17M |
Impairment and provision | 195.83%71K | -129.21%-151K | -79.35%82K | -71.43%24K | -109.09%-3K | 249.32%517K | 133.53%397K | -37.31%84K | -89.42%33K | 103.00%148K |
-Other impairment is provision | 195.83%71K | -129.21%-151K | -79.35%82K | -71.43%24K | -109.09%-3K | 249.32%517K | 133.53%397K | -37.31%84K | -89.42%33K | 103.00%148K |
Special items of operating profit | -5.11%2.88M | 30.52%5.62M | 4,473.86%4.03M | 2,900.99%3.03M | 112.88%843K | 595.48%4.31M | -93.26%88K | -87.30%101K | 48.31%396K | -78.77%619K |
Operating profit | 29.84%7.86M | -30.64%11.16M | -27.66%8.03M | -35.33%6.06M | -15.29%3.18M | 35.03%16.09M | 5.22%11.09M | 33.56%9.36M | 26.07%3.75M | 212.99%11.92M |
Financing cost | -111.76%-3.03M | -115.40%-4.06M | -102.79%-2.32M | -74.91%-1.43M | -11.74%-457K | -33.36%-1.88M | -4.19%-1.15M | -24.54%-817K | -39.12%-409K | -2.77%-1.41M |
Earning before tax | 4.54%4.84M | -50.00%7.11M | -42.67%5.7M | -45.86%4.63M | -18.60%2.72M | 35.25%14.21M | 5.34%9.95M | 34.49%8.55M | 24.64%3.34M | 188.12%10.51M |
Tax | 23.75%-2.68M | -18.40%-6.6M | -43.15%-5.38M | -21.47%-3.51M | -0.57%-1.24M | -52.30%-5.57M | -19.21%-3.76M | -31.75%-2.89M | -25.87%-1.23M | -67.11%-3.66M |
After-tax profit from continuing operations | 93.21%2.16M | -94.10%510K | -94.84%319K | -80.23%1.12M | -29.77%1.48M | 26.15%8.64M | -1.62%6.19M | 35.94%5.66M | 23.93%2.11M | 148.53%6.85M |
Earning after tax | 93.21%2.16M | -94.10%510K | -94.84%319K | -80.23%1.12M | -29.77%1.48M | 26.15%8.64M | -1.62%6.19M | 35.94%5.66M | 23.93%2.11M | 148.53%6.85M |
Profit attributable to shareholders | 93.21%2.16M | -94.10%510K | -94.84%319K | -80.23%1.12M | -29.77%1.48M | 26.15%8.64M | -1.62%6.19M | 35.94%5.66M | 23.93%2.11M | 148.53%6.85M |
Basic earnings per share | 93.75%0.0031 | -94.26%0.0007 | -94.32%0.0005 | -80.00%0.0016 | -30.00%0.0021 | 25.77%0.0122 | -1.12%0.0088 | 35.59%0.008 | 25.00%0.003 | 148.50%0.0097 |
Diluted earnings per share | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Kadoorie Certified Public Accountants Ltd | -- | -- | -- | Kadoorie Certified Public Accountants Ltd | -- | -- | -- | Kadoorie Certified Public Accountants Ltd |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data